HS
ALNY icon

HighVista Strategies’s Alnylam Pharmaceuticals ALNY Stock Holding History

HighVista Strategies’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1,551
Closed -$427K – 141
2024
Q3 		$427K Sell
1,551
-1,051
-40% -$274K 0.15% 136
2024
Q2 		$632K Buy
+2,602
New +$411K 0.23% 112
2023
Q3 		– Sell
-4,056
Closed -$770K – 134
2023
Q2 		$770K Hold
4,056
– – 0.35% 72
2023
Q1 		$812K Hold
4,056
– – 0.66% 47
2022
Q4 		$964K Sell
4,056
-183
-4% -$39K 0.57% 46
2022
Q3 		$848K Sell
4,239
-749
-15% -$143K 0.48% 50
2022
Q2 		$728K Sell
4,988
-567
-10% -$80.4K 0.44% 53
2022
Q1 		$907K Sell
5,555
-1,538
-22% -$234K 0.58% 42
2021
Q4 		$1.2M Buy
7,093
+935
+15% +$174K 0.96% 33
2021
Q3 		$1.16M Buy
+6,158
New +$1.16M 0.77% 40
2020
Q3 		– Sell
-2,805
Closed -$415K – 117
2020
Q2 		$415K Buy
+2,805
New +$378K 0.34% 55

Other funds holding ALNY

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
RP
Regeneron Pharmaceuticals Tarrytown, New York $47.9M AUM 29.29% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return